Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Breast Cancer Research
  • View item
  • Home
  • ICR Divisions
  • Breast Cancer Research
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Characterizing genetic variants for clinical action.

Thumbnail
View/Open
Accepted version (197.3Kb)
Date
2014-03-13
ICR Author
Rahman, Sabera
Author
Ramos, EM
Din-Lovinescu, C
Berg, JS
Brooks, LD
Duncanson, A
Dunn, M
Good, P
Hubbard, TJP
Jarvik, GP
O'Donnell, C
Sherry, ST
Aronson, N
Biesecker, LG
Blumberg, B
Calonge, N
Colhoun, HM
Epstein, RS
Flicek, P
Gordon, ES
Green, ED
Green, RC
Hurles, M
Kawamoto, K
Knaus, W
Ledbetter, DH
Levy, HP
Lyon, E
Maglott, D
McLeod, HL
Rahman, N
Randhawa, G
Wicklund, C
Manolio, TA
Chisholm, RL
Williams, MS
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
Genome-wide association studies, DNA sequencing studies, and other genomic studies are finding an increasing number of genetic variants associated with clinical phenotypes that may be useful in developing diagnostic, preventive, and treatment strategies for individual patients. However, few variants have been integrated into routine clinical practice. The reasons for this are several, but two of the most significant are limited evidence about the clinical implications of the variants and a lack of a comprehensive knowledge base that captures genetic variants, their phenotypic associations, and other pertinent phenotypic information that is openly accessible to clinical groups attempting to interpret sequencing data. As the field of medicine begins to incorporate genome-scale analysis into clinical care, approaches need to be developed for collecting and characterizing data on the clinical implications of variants, developing consensus on their actionability, and making this information available for clinical use. The National Human Genome Research Institute (NHGRI) and the Wellcome Trust thus convened a workshop to consider the processes and resources needed to: (1) identify clinically valid genetic variants; (2) decide whether they are actionable and what the action should be; and (3) provide this information for clinical use. This commentary outlines the key discussion points and recommendations from the workshop.
URI
https://repository.icr.ac.uk/handle/internal/1851
DOI
https://doi.org/10.1002/ajmg.c.31386
Collections
  • Breast Cancer Research
  • Genetics and Epidemiology
Subject
Humans
Information Dissemination
Phenotype
Education
Medical Informatics
United States
National Human Genome Research Institute (U.S.)
Genetic Variation
Precision Medicine
Research team
Genetic Susceptibility
Language
eng
License start date
2014-03-13
Citation
American journal of medical genetics. Part C, Seminars in medical genetics, 2014, 166C (1), pp. 93 - 104

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.